The Impact of Probiotic Bacteria on the Efficacy of Anti-retroviral Therapy and Recurrence of Bacterial Vaginosis

Sponsor
Lawson Health Research Institute (Other)
Overall Status
Completed
CT.gov ID
NCT01258556
Collaborator
(none)
150
1
2

Study Details

Study Description

Brief Summary

Purpose of the proposed research is to determine the impact of probiotic yogurt supplemented with Lactobacillus rhamnosus (Fiti) compared to regular yogurt on the well-being of women living with HIV.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Yogurt supplemented with L. rhamnosus fiti
  • Dietary Supplement: Yogurt not supplemented with a probiotic strain.
Phase 2/Phase 3

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Study Start Date :
Jun 1, 2010
Actual Primary Completion Date :
Jul 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: Probiotic yogurt

Dietary Supplement: Yogurt supplemented with L. rhamnosus fiti
200 ml of L. rhamnosus fiti at 10*9 cfu/ml daily for 30 days.

Placebo Comparator: Placebo yogurt.

Dietary Supplement: Yogurt not supplemented with a probiotic strain.
200 ml yoghurt without L. rhamnosus fiti daily for 30 days.

Outcome Measures

Primary Outcome Measures

  1. Vaginal microbiota of HIV patients. [30 days]

Secondary Outcome Measures

  1. Bacterial vaginosis. [30 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion criteria:
  • Confirmed HIV infection;

  • Being treated with anti-retroviral medication for > 6 months.

Exclusion criteria:
  • Pregnancy;

  • Hypersensitive to fermented milk;

  • Intolerant for lactose;

  • Complaints of bacterial vaginosis requiring treatment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sekou-Toure Regional Hospital Mwanza Tanzania

Sponsors and Collaborators

  • Lawson Health Research Institute

Investigators

  • Principal Investigator: Nicodemus Butamanya, MD, Sekou-Toure Regional Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01258556
Other Study ID Numbers:
  • 919
First Posted:
Dec 13, 2010
Last Update Posted:
Dec 13, 2010
Last Verified:
Dec 1, 2010
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 13, 2010